Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Hematology & Oncology|May 20, 2020
Gene modification strategies for next-generation CAR T cells against solid cancersYonggui Tian, Yilu Li, Yupei Shao, et al.Journal for Immunotherapy of Cancer|October 7, 2020
Point mutation in CD19 facilitates immune escape of B cell lymphoma from CAR-T cell therapyZhen Zhang, Xinfeng Chen, Yonggui Tian, et al.Cancer Immunology, Immunotherapy : CII|January 3, 2025
CCR5 and IL-12 co-expression in CAR T cells improves antitumor efficacy by reprogramming tumor microenvironment in solid tumorsYonggui Tian, Liubo Zhang, Yu Ping, et al.Cancer Immunology, Immunotherapy : CII|March 30, 2022
CXCL9-modified CAR T cells improve immune cell infiltration and antitumor efficacyYonggui Tian, Chunli Wen, Zhen Zhang, et al.BMC Medicine|November 25, 2021
Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathwayChunyi Shen, Zhen Zhang, Yonggui Tian, et al.Frontiers in Immunology|July 1, 2021
PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung CancerChunyi Shen, Chaojun Liu, Zhen Zhang, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 30, 2020
Metformin Enhances the Antitumor Activity of CD8+ T Lymphocytes via the AMPK-miR-107-Eomes-PD-1 PathwayZhen Zhang, Feng Li, Yonggui Tian, et al.Cytotherapy|February 27, 2022
Long-term clinical efficacy of cytokine-induced killer cell-based immunotherapy in early-stage esophageal squamous cell carcinomaYanfen Liu, Zhen Zhang, Yonggui Tian, et al.Pageof 1